Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - INFINITY PHARMACEUTICALS, INC. | Financial_Report.xls |
| EX-31.1 - CERTIFICATION OF PEO AND PFO PURSUANT TO SECTION 302 - INFINITY PHARMACEUTICALS, INC. | d262279dex311.htm |
| EX-23.1 - CONSENT OF ERNST & YOUNG LLP - INFINITY PHARMACEUTICALS, INC. | d262279dex231.htm |
| EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - INFINITY PHARMACEUTICALS, INC. | d262279dex211.htm |
| 10-K - FORM 10-K - INFINITY PHARMACEUTICALS, INC. | d262279d10k.htm |
EXHIBIT 32.1
STATEMENT PURSUANT TO 18 U.S.C. §1350
Pursuant to 18 U.S.C. §1350, the undersigned certifies that this Annual Report on Form 10-K for the period ended December 31, 2011 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of Infinity Pharmaceuticals, Inc.
| Dated: March 13, 2012 | /s/ ADELENE Q. PERKINS
| |||||
| Adelene Q. Perkins | ||||||
| President and Chief Executive Officer | ||||||
| (Principal Executive Officer and Principal Financial Officer) | ||||||
A signed original of this written statement required by Section 906 has been provided to Infinity Pharmaceuticals, Inc. and will be retained by Infinity Pharmaceuticals, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.